Printer Friendly

Browse Psoriatic arthritis topic

Drug therapy subtopic

Articles

1-34 out of 34 article(s)
Title Author Type Date Words
Herpes zoster risk increased with some psoriasis, psoriatic arthritis treatments. Nogrady, Bianca Oct 1, 2019 685
Abbvie (NYSE: ABBV) - AbbVie Announces First Regulatory Approval of SKYRIZI[TM] (risankizumab) for the Treatment of Plaque Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis and Psoriatic Arthritis in Japan - 26/3/2019. Apr 1, 2019 430
Pfizer receives US FDA approval for psoriatic arthritis drugs Xeljanz and Xeljanz XR. Dec 18, 2017 226
Pfizer receives US FDA approval for psoriatic arthritis drugs Xeljanz and Xeljanz XR. Dec 18, 2017 222
FDA Approves Xeljanz (tofacitinib) and Xeljanz XR for Treatment of Active Psoriatic Arthritis. Dec 18, 2017 402
US FDA Approves Taltz (ixekizumab) for Treatment of Active Psoriatic Arthritis. Dec 4, 2017 277
Lilly wins US FDA approval for Taltz (ixekizumab) for the treatment of active psoriatic arthritis. Dec 4, 2017 245
Lilly wins US FDA approval for Taltz (ixekizumab) for the treatment of active psoriatic arthritis. Dec 4, 2017 241
FDA Advisory Committee Votes in Favour of Xeljanz (tofacitinib citrate) for the Treatment of Active Psoriatic Arthritis. Aug 4, 2017 376
Psoriatic arthritis: pathogenesis and treatment. Furst, Daniel E. Aug 1, 2017 2052
FDA Grants Approval to Bristol-Myers Squibb for Orencia (abatacept) for Treatment of Active Psoriatic Arthritis in Adults. Jul 7, 2017 192
US FDA Accepts Pfizer's Supplemental New Drug Application FIling for Xeljanz for Active Psoriatic Arthritis. May 5, 2017 520
UK's NICE approves Celgene's psoriatic arthritis drug Otezla. Oct 12, 2016 226
UK's NICE approves Celgene's psoriatic arthritis drug Otezla. Oct 12, 2016 222
Diplomat to launch US FDA approved COSENTYX for ankylosing spondylitis and psoriatic arthritis. Jan 21, 2016 194
Diplomat to launch US FDA approved COSENTYX for ankylosing spondylitis and psoriatic arthritis. Jan 21, 2016 190
Eular's psoriatic arthritis recommendations add drugs. Zoler, Mitchel L. Aug 1, 2015 619
FDA approves oral drug for psoriatic arthritis. Mar 25, 2014 655
Drug retention rates and treatment discontinuation among anti-TNF-[alpha] agents in psoriatic arthritis and ankylosing spondylitis in clinical practice. Fabbroni, Marta; Cantarini, Luca; Caso, Francesco; Costa, Luisa; Pagano, Veronica Anna; Frediani, Br Report Jan 1, 2014 5128
FDA approves UCB's Cimzia for adults with active psoriatic arthritis. Oct 1, 2013 223
Methotrexate in psoriatic arthritis. Mease, Philip Report Jan 15, 2013 3772
Update on treatment of psoriatic arthritis. Mease, Philip Jul 1, 2012 3830
Psoriatic arthritis: treatment update. Mease, Philip J. Jul 1, 2011 5153
NICE recommends Merck & Co's Simponi for treatment of psoriatic arthritis. Disease/Disorder overview Mar 18, 2011 199
Psoriatic arthritis: update on pathophysiology, assessment, and management. Mease, Philip J. Disease/Disorder overview Jul 1, 2010 6362
Long-term adalimumab proves safe and effective for psoriatic arthritis. Worcester, Sharon Clinical report Mar 1, 2008 513
New data reinforce safety profile of Enbrel (etanercept). Apr 1, 2007 573
Adalimumab helps skin disease in psoriatic arthritis. Boschert, Sherry Brief article May 15, 2006 252
Biologic resolves all severities of psoriatic arthritis. Boschert, Sherry Brief article Apr 15, 2006 287
Third TNF-blocker targets psoriatic arthritis. Dixon, Bruce K. Dec 15, 2005 824
Etanercept's safety similar in all age groups. Finn, Robert Brief Article Nov 1, 2005 245
Remicade eyed for psoriatic arthritis by FDA. Finn, Robert Brief Article Jan 1, 2005 229
Pilot study shows adalimumab gets rapid results in psoriatic arthritis. Jancin, Bruce Brief Article Aug 15, 2004 287
Enbrel. (New & Approved). Mechcatie, Elizabeth Feb 15, 2002 296

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters